Fluicell AB (publ) (STO:FLUI)
13.35
+0.30 (2.30%)
Apr 24, 2026, 5:15 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 18.34 million as of April 24, 2026. Its market cap has decreased by -2.55% in one year.
Market Cap
18.34M
Enterprise Value
16.08M
Revenue
15.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.35
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 18.34M, a decrease of -83.88%. That is a compound annual growth rate of -20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 17.93M | 30.50% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 79.06M |
| Pila Pharma AB | 76.52M |
| Nanologica AB | 74.62M |
| AcouSort AB | 69.21M |
| Modus Therapeutics Holding AB | 51.45M |
| 2cureX AB | 48.15M |
| Biosergen AB | 22.66M |
| NanoEcho AB | 21.26M |